ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Wearable Hyperspectral Photoplethysmography Allows Continuous Monitoring of Exercise-Induced Hypertension.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Seamless human electronics interfacing through advanced skin attachable and implantable sensor technologies.Discover nano · 2026Review
- Wearable Flexible Sensors for Cardiovascular Disease Monitoring.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Intrinsic PPG-ECG Coupling for Accurate and Low-Power Blood Pressure Monitoring.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Fever Inspiration: Precision Engineering for Safe and Systemic Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Wearable Hyperspectral Photoplethysmography Allows Continuous Monitoring of Exercise-Induced Hypertension.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Continuous blood pressure (BP) monitoring is essential for cardiovascular health, yet current BP sensors face cuff-dependent limitations. Cuff-free alternatives still suffer from discomfort and discontinuous measurement. Here a wearable hyperspectral photoplethysmography (HS-PPG) is reported for continuous and nonconscious BP monitoring. The HS-PPG module integrates an ultrathin and high-resolution double-folded solid immersion grating microspectrometer (DFSIG-µSPEC) with a white light LED. DFSIG-µSPEC shows an average spectral resolution of 3.4 nm for 550-800 nm in the operational range. The HS-PPG module has a compact physical dimension of 8 mm × 16 mm × 24 mm, suitable for wrist-wearable configuration. The PPG waveforms contain 50 spectral bands, achieving precise measurement of arteriolar pulse transit time (aPTT). The diastolic and systolic BPs are precisely estimated with R-values of 0.92 and 0.96, and mean absolute differences (MAD) of 1.20 and 0.40 mmHg with the 2-element Windkessel model, respectively. Further, the BP is continuously measured with heart rate (HR) and respiratory exchange ratio (RER) with exercise-induced hypertension. Continuous monitoring of systolic blood pressure (SBP) exhibits immediate responses during hemodynamic changes, with the physiological parameters of SBP, HR, and RER during exercise and recovery. The wearable HS-PPG clearly supports the strong potential for high-fidelity continuous BP monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.